U.S. flag

An official website of the United States government

NM_000398.7(CYB5R3):c.350C>G (p.Thr117Ser) AND NADH-CYTOCHROME b5 REDUCTASE POLYMORPHISM

Germline classification:
Benign (1 submission)
Last evaluated:
May 1, 2008
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000000268.10

Allele description [Variation Report for NM_000398.7(CYB5R3):c.350C>G (p.Thr117Ser)]

NM_000398.7(CYB5R3):c.350C>G (p.Thr117Ser)

Gene:
CYB5R3:cytochrome b5 reductase 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q13.2
Genomic location:
Preferred name:
NM_000398.7(CYB5R3):c.350C>G (p.Thr117Ser)
HGVS:
  • NC_000022.11:g.42628265G>C
  • NG_012194.1:g.26135C>G
  • NM_000398.7:c.350C>GMANE SELECT
  • NM_001129819.2:c.281C>G
  • NM_001171660.2:c.449C>G
  • NM_001171661.1:c.281C>G
  • NM_007326.4:c.281C>G
  • NP_000389.1:p.Thr117Ser
  • NP_001123291.1:p.Thr94Ser
  • NP_001165131.1:p.Thr150Ser
  • NP_001165132.1:p.Thr94Ser
  • NP_015565.1:p.Thr94Ser
  • NC_000022.10:g.43024271G>C
  • NM_000398.6:c.350C>G
  • P00387:p.Thr117Ser
Protein change:
T117S; THR117SER
Links:
UniProtKB: P00387#VAR_010751; OMIM: 613213.0011; dbSNP: rs1800457
NCBI 1000 Genomes Browser:
rs1800457
Molecular consequence:
  • NM_000398.7:c.350C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001129819.2:c.281C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171660.2:c.449C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171661.1:c.281C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007326.4:c.281C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
NADH-CYTOCHROME b5 REDUCTASE POLYMORPHISM
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000020412OMIM
no assertion criteria provided
Benign
(May 1, 2008)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency.

Percy MJ, Lappin TR.

Br J Haematol. 2008 May;141(3):298-308. doi: 10.1111/j.1365-2141.2008.07017.x. Epub 2008 Mar 3. Review.

PubMed [citation]
PMID:
18318771

A high-frequency polymorphism of NADH-cytochrome b5 reductase in African-Americans.

Jenkins MM, Prchal JT.

Hum Genet. 1997 Feb;99(2):248-50.

PubMed [citation]
PMID:
9048929

Details of each submission

From OMIM, SCV000020412.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

This variant, originally reported as THR116SER, has been designated THR117SER based on revised numbering (Percy and Lappin, 2008).

Jenkins and Prchal (1997) claimed to have demonstrated the first polymorphism in the CYB5R3 gene: a C-to-G transversion in exon 5, resulting in a thr117-to-ser (T117S) substitution. The polymorphism was found only in African Americans among whom 26 of 112 chromosomes showed the G form, giving an allele frequency of 0.23. It was not found in 108 Caucasian, 46 Asian, 44 Indo-Aryan, or 14 Arabic chromosomes. Preliminary studies indicated that the polymorphism did not correlate with enzyme activity or produce any disease phenotype. It remained to be determined whether this African-specific polymorphism that apparently originated recently in human evolution provides any special survival advantage.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024